Lacosamide 53746-0925-05
- Manufacturer
- Amneal Pharmaceuticals Of New York Llc
- Dosage Form
- Tablet
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- May 17, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA204857
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 150 mg/1 |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
53746-0925-05Selected500 TABLET in 1 BOTTLE (53746-925-05)
Other packages for this product(1)
60 TABLET in 1 BOTTLE (53746-925-60)